Searched for
FTC PHARMACEUTICAL
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- Pfizer weighs sweeter offer for Metsera after Judge blocks bid to halt Novo Nordisk’s $10 billion takeoverPfizer is increasing its offer for Metsera. This comes after a judge rejected Pfizer's attempt to stop rival Novo Nordisk's bid. Pfizer's d...
- Donald Trump's pharma pricing diktat details and how it can be legally challengedPresident Trump signed an executive order aimed at lowering U.S. drug prices to match those of other countries, prompting industry concerns...
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Lupin launches generic insomnia drug in USDrug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
- Lupin, Gavis to sell 2 drugs to fulfil US FTC conditionThe acquisition creates the fifth largest portfolio of abbreviated new drug application (ANDA) filings with the USFDA, addressing a USD 63....
- Sun-Ranbaxy $4 billion deal: US anti-trust regulator FTC passes final orderFTC has passed its final order settling charges that Sun Pharma's $4 billion deal to acquire Ranbaxy Laboratories could result in unfair bu...
- US Federal Trade Panel wraps up review of Sun Pharms's Ranbaxy acquisitionSun Pharmaceutical has moved closer to wrapping up its proposed acquisition of Ranbaxy Laboratories with the US Federal Trade Commission co...
- Ranbaxy, Sun Pharma gain on merger nodRanbaxy Laboratories rose by 2.37% to settle at Rs 720.35 on the BSE. In intra-day trade, it jumped 3.46% to touch 52-week high of Rs 728.
- Sun Pharma gets US FTC clearance for Ranbaxy acquisitionThe early termination of the waiting period under the HSR Act satisfies one of the essential conditions to the closing of the Ranbaxy acqui...
- Sun Pharma, Ranbaxy get USFTC conditional nod for merger;stks gainThe USFTC has asked Ranbaxy to sell generic minocycline drug rights to meet fair trade norm. Torrent Pharma is reported to buy minocycline ...
- US regulator imposes conditions on Sun Pharmaceuticals' Ranbaxy acquisitionTorrent Pharmaceuticals, a global drug company based in India that markets generic drugs in the United States, will acquire the divested as...
- Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...
- Drug cos patent settlements to cost Americans $3.5 bn annuallyCash settlements of patent disputes between innovator companies and generic medicine makers are delaying entry of affordable drugs in US ma...
- Sun's Caraco settles litigation with Forest Lab in USThe Rs 4,300-crore Sun Pharmaceuticals Ltd's US-subsidiary, Caraco Pharmaceuticals Laboratories Ltd, has gone for settlement of the legal p...
- Sun to give up 3 drugs for TaroSun Pharmaceutical Industries has agreed to sell the assets and rights of three generic drugs, which it sells in the US market, to Torrent ...
- South Korean drug firms fined $22 mn over kickbacksSouth Korea's anti-trust watchdog said Thursday it has fined 10 local pharmaceutical companies a total of 19.97 billion won (22.2 million d...
- Plavix Accord: Bristol-Myers, Sanofi face criminal probeSanofi-Aventis said the US started a criminal probe of a plan to keep a generic version of their top-selling blood-thinner Plavix off the m...
Load More
